DE60303312D1 - Thrombinspaltbare faktor-x-analoga - Google Patents

Thrombinspaltbare faktor-x-analoga

Info

Publication number
DE60303312D1
DE60303312D1 DE60303312T DE60303312T DE60303312D1 DE 60303312 D1 DE60303312 D1 DE 60303312D1 DE 60303312 T DE60303312 T DE 60303312T DE 60303312 T DE60303312 T DE 60303312T DE 60303312 D1 DE60303312 D1 DE 60303312D1
Authority
DE
Germany
Prior art keywords
factor
thrombin
splitable
analogue
arg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60303312T
Other languages
English (en)
Other versions
DE60303312T2 (de
Inventor
Virginie Louvain
Elsa Bianchini
Pierre-Emmanuel Marque
Claire Calmel-Tareau
Martine Aiach
Bonniec Bernard Le
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Publication of DE60303312D1 publication Critical patent/DE60303312D1/de
Application granted granted Critical
Publication of DE60303312T2 publication Critical patent/DE60303312T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6432—Coagulation factor Xa (3.4.21.6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21006—Coagulation factor Xa (3.4.21.6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE60303312T 2002-07-03 2003-06-30 Thrombin-spaltbare faktor x-derivate Expired - Lifetime DE60303312T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0208299A FR2841904B1 (fr) 2002-07-03 2002-07-03 Analogues de facteurs x clivables par la thrombine
FR0208299 2002-07-03
PCT/EP2003/007793 WO2004005347A1 (en) 2002-07-03 2003-06-30 Thrombin-cleavable factor x analogues

Publications (2)

Publication Number Publication Date
DE60303312D1 true DE60303312D1 (de) 2006-04-06
DE60303312T2 DE60303312T2 (de) 2006-09-21

Family

ID=29725108

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60303312T Expired - Lifetime DE60303312T2 (de) 2002-07-03 2003-06-30 Thrombin-spaltbare faktor x-derivate

Country Status (10)

Country Link
US (1) US8168753B2 (de)
EP (1) EP1539816B1 (de)
JP (1) JP4533137B2 (de)
AT (1) ATE316101T1 (de)
AU (1) AU2003250095B2 (de)
CA (1) CA2491040C (de)
DE (1) DE60303312T2 (de)
ES (1) ES2257693T3 (de)
FR (1) FR2841904B1 (de)
WO (1) WO2004005347A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2831170B1 (fr) 2001-10-19 2004-03-19 Inst Nat Sante Rech Med Proteines c modifiees activables directement par la thrombine
EP1728798A1 (de) * 2005-06-01 2006-12-06 ZLB Behring GmbH Blutgerinnungsfaktor X Polypeptide mit veränderten Aktivierungseigenschaften
MX2008006313A (es) * 2005-11-15 2008-11-06 Philadelphia Children Hospital Metodos y composiciones para modular la hemostasia.
EP1816201A1 (de) 2006-02-06 2007-08-08 CSL Behring GmbH Modifizierter Koagulationsfaktor VIIa mit verbesserter 'half-life'-Stabiltät
EP1820508A1 (de) 2006-02-21 2007-08-22 CSL Behring GmbH Polypeptide des Gerinnfaktors X mit geänderten Aktivierungseigenschaften
US8754194B2 (en) 2006-12-22 2014-06-17 Csl Behring Gmbh Modified coagulation factors with prolonged in vivo half-life
WO2010070137A1 (en) 2008-12-19 2010-06-24 INSERM (Institut National de la Santé et de la Recherche Médicale) Serine protease derivatives and uses in the prevention or the treatment of blood coagulation disorders
US9371522B2 (en) 2011-09-30 2016-06-21 The Children's Hospital Of Philadelphia Compositions and methods for modulating hemostasis
EP4079316A1 (de) 2012-06-08 2022-10-26 Bioverativ Therapeutics Inc. Prokoagulatorische verbindungen
WO2013185114A2 (en) 2012-06-08 2013-12-12 Biogen Idec Ma Inc. Chimeric clotting factors
US9145552B2 (en) 2012-07-25 2015-09-29 Catalyst Biosciences, Inc. Modified factor X polypeptides and uses thereof
MX2015008813A (es) 2013-01-31 2016-03-31 Pfizer Composiciones y metodos para contrarrestar la inhibicion del factor xa.
FR3001729B1 (fr) * 2013-02-04 2015-03-06 Lab Francais Du Fractionnement Mutants du facteur x
US20160024487A1 (en) * 2013-03-12 2016-01-28 Novo Nordisk A/S Thrombin sensitive coagulation factor x molecules
MX2016003871A (es) 2013-09-24 2016-08-04 Pfizer Composiciones que comprenden poblaciones heterogeneas de proteinas recombinantes humanas de factor xa de coagulacion.
US10676731B2 (en) 2014-08-19 2020-06-09 The Children's Hospital Of Philadelphia Compositions and methods for modulating factor IX function

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS634615A (ja) * 1986-06-25 1988-01-09 Hitachi Tokyo Electron Co Ltd 半導体装置製造装置
GB9222758D0 (en) * 1992-10-29 1992-12-09 British Bio Technology Proteins and nucleic acids
US5746875A (en) * 1994-09-16 1998-05-05 Applied Materials, Inc. Gas injection slit nozzle for a plasma process reactor
US6043218A (en) * 1996-10-22 2000-03-28 Medical University Of South Carolina Positively charged non-natural amino acids, methods of making thereof, and use thereof in peptides
DE69733660T2 (de) * 1996-11-04 2006-05-18 Materials Modification, Inc. Mikrowellenplasma chemischen synthese von ultrafeinen pulvern
AT405516B (de) * 1997-02-27 1999-09-27 Immuno Ag Faktor x-analoge mit modifizierter proteasespaltstelle
CH697092A5 (de) * 1998-12-24 2008-04-30 Sulzer Metco Ag Anordnung für eine Plasmaspritzanlage.

Also Published As

Publication number Publication date
DE60303312T2 (de) 2006-09-21
US8168753B2 (en) 2012-05-01
JP4533137B2 (ja) 2010-09-01
CA2491040C (en) 2012-05-01
JP2006507806A (ja) 2006-03-09
US20060148038A1 (en) 2006-07-06
AU2003250095B2 (en) 2009-04-09
FR2841904A1 (fr) 2004-01-09
AU2003250095A1 (en) 2004-01-23
ES2257693T3 (es) 2006-08-01
FR2841904B1 (fr) 2004-08-20
EP1539816A1 (de) 2005-06-15
EP1539816B1 (de) 2006-01-18
CA2491040A1 (en) 2004-01-15
WO2004005347A1 (en) 2004-01-15
ATE316101T1 (de) 2006-02-15

Similar Documents

Publication Publication Date Title
DE60303312D1 (de) Thrombinspaltbare faktor-x-analoga
HUP0100652A1 (hu) X-Faktor analógok módosított proteáz hasítási hellyel
ATE446313T1 (de) Muteine von tränen-lipocalin
GEP20063741B (en) Nonaryl-Heterocyclic NMDA/NR2B Antagonists
PA8446001A1 (es) Derivados de n-hidroxi-b-sulfonilpropionamida
MXPA02006029A (es) Lipopeptidos novedosos como agentes antibacterianos.
MX9300800A (es) Polimeros de beta-dicarbonilo y sistema para formar un cemento a partir de los mismos.
ATE549028T1 (de) Stabile analoga von glp-1
CY1110602T1 (el) Φαρμακευτικες συνθεσεις υπο μορφη γελης ή διαλυματος με βαση τη διυδροτεστοστερονη, μεθοδοι παρασκευης και χρησεις τους
SE0301653D0 (sv) Novel compounds
UA87335C2 (en) Gel composition of 4-hydroxytamoxifen
BR122018075729B8 (pt) flavivírus na preparação de uma composição de vacina
RS90904A (en) Novel perindopril salt and pharmaceutical compositions containing same
DE50204688D1 (de) N-alkylaziridinoprepolymere als dentalmasse
BR0211761A (pt) depsipeptìdeos e processos para preparar os mesmos
PT1407763E (pt) Composicoes contendo um acido organico cosmeticamente activo e um produto a base de uma leguminosa
ATE380174T1 (de) Arginin-mimetika als faktor xa-inhibitoren
ATE282607T1 (de) Tryptase-inhibitoren
ATE357245T1 (de) Biologisch stabile flüssige zusammensetzung von fviii, vwf oder fviii/vwf-komplex menschlichen ursprungs
DE602006020155D1 (de) Pharmazeutische wundheilungs-zusammensetzungen in ren und natriumhyaluronat
HUP0400976A2 (hu) VII-es faktor polipeptideket és XI-es faktor polipeptideket tartalmazó gyógyszerészeti összetételek
ATE488475T1 (de) Aerosolierte keramikporzellane und glasurzusammensetzungen
HUP0202729A2 (hu) Ösztramusztin-foszfátot és aminosavakat tartalmazó, parenteralis felhasználásra szolgáló készítmények
ATE457188T1 (de) Kompositmaterialien aus calciumverbindungen und glucuronsäurehaltigen polysacchariden
ATE384078T1 (de) Paralytisches peptide von der spitzmaus sowie dessen nutzung in der therapie von neuromuskulären krankheiten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition